Herpes Zoster Infection in Patients With Ulcerative Colitis Receiving Tofacitinib

Inflammatory Bowel Diseases
Kevin L WinthropChinyu Su

Abstract

Tofacitinib is an oral, small molecule Janus kinase inhibitor that is being investigated for ulcerative colitis (UC). Tofacitinib is approved for rheumatoid arthritis and psoriatic arthritis, where it has been shown to increase herpes zoster (HZ) risk. We evaluated HZ risk among UC patients using tofacitinib. HZ cases were identified in tofacitinib phase II/III/ongoing, open-label, long-term extension (OLE) UC trials. We calculated HZ incidence rates (IRs) per 100 patient-years of tofacitinib exposure within phase III maintenance (Maintenance Cohort) and phase II/III/OLE (Overall Cohort) studies, stratified by baseline demographics and other factors. HZ risk factors were evaluated in the Overall Cohort using Cox proportional hazard models. Overall, 65 (5.6%) patients developed HZ. Eleven patients had multidermatomal involvement (2 nonadjacent or 3-6 adjacent dermatomes), and 1 developed encephalitis (resolved upon standard treatment). Five (7.7%) events led to treatment discontinuation. HZ IR (95% confidence interval [CI]) in the Overall Cohort was 4.07 (3.14-5.19) over a mean (range) of 509.1 (1-1606) days, with no increased risk observed with increasing tofacitinib exposure. IRs (95% CI) were highest in patients age ≥65 years...Continue Reading

References

Aug 24, 2004·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Lene Malmgaard
Jun 3, 2005·The New England Journal of Medicine·M N OxmanUNKNOWN Shingles Prevention Study Group
Dec 13, 2006·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Gauree GuptaJames D Lewis
Jun 19, 2007·The Clinical Journal of Pain·Kenneth E SchmaderMichael N Oxman
Dec 18, 2012·Alimentary Pharmacology & Therapeutics·M D LongM D Kappelman
Jan 15, 2014·Journal of Medicinal Chemistry·James D ClarkJean-Baptiste Telliez
Apr 23, 2014·Nature Reviews. Immunology·Markus F Neurath
Jun 20, 2014·Arthritis & Rheumatology·Kevin L WinthropRichard Riese
Apr 29, 2015·The New England Journal of Medicine·Himal LalUNKNOWN ZOE-50 Study Group
Mar 19, 2016·Arthritis & Rheumatology·Huifeng YunJeffrey R Curtis
May 14, 2016·Expert Opinion on Investigational Drugs·Roberta IzzoGiovanni Monteleone
Dec 5, 2016·Lancet·Ryan UngaroJean-Frédéric Colombel
Mar 3, 2017·Nature Reviews. Rheumatology·Kevin L Winthrop
May 4, 2017·The New England Journal of Medicine·William J SandbornUNKNOWN OCTAVE Induction 1, OCTAVE Induction 2, and OCTAVE Sustain Investigators
Jul 18, 2017·Journal of the American Academy of Dermatology·Kevin L WinthropHernan Valdez
Aug 29, 2017·Arthritis & Rheumatology·Kevin L WinthropEustratios Bananis

❮ Previous
Next ❯

Citations

Oct 5, 2018·Expert Review of Clinical Immunology·Agnès Fernández-ClotetJulián Panés
Apr 25, 2019·Current Gastroenterology Reports·Tushar Shukla, Bruce E Sands
Jan 4, 2019·Inflammatory Bowel Diseases·Freddy CalderaRaymond K Cross
May 24, 2019·Alimentary Pharmacology & Therapeutics·Christopher MaVipul Jairath
Apr 27, 2019·Journal of Gastroenterology·Masaaki HigashiyamaRyota Hokari
Aug 29, 2019·Expert Opinion on Pharmacotherapy·Hunar AbdulrahimAdewale O Adebajo
Oct 31, 2019·The Journal of Dermatological Treatment·Derek NiePeter A Lio
Sep 6, 2019·Current Gastroenterology Reports·Christopher M JohnsonThemistocles Dassopoulos
Jan 1, 2020·Journal of Crohn's & Colitis·Rachel E HarrisRichard K Russell
Mar 12, 2020·Journal of Crohn's & Colitis·Pavine L C Lefevre, Niels Vande Casteele
Nov 11, 2019·Clinical Journal of Gastroenterology·Keiichi TominagaAtsushi Irisawa
Jun 11, 2020·Expert Review of Gastroenterology & Hepatology·Giulia RodaSilvio Danese
Feb 2, 2020·Journal of Crohn's & Colitis·Manasi AgrawalJean-Frederic Colombel
Jan 11, 2020·Journal of Crohn's & Colitis·Britta Siegmund
Jun 28, 2020·Journal of Crohn's & Colitis·Philipp SchreinerLuc Biedermann
Sep 3, 2020·Journal of Pharmacy Practice·Brittany N Palasik, Hongmei Wang
Mar 12, 2020·Current Drug Metabolism·Fabio Salvatore Macaluso, Iago Rodríguez-Lago
Jan 28, 2020·The Cochrane Database of Systematic Reviews·Sarah C DaviesVipul Jairath
Feb 1, 2020·Current Gastroenterology Reports·Shannon Chang, David Hudesman
Mar 24, 2020·Nature Reviews. Gastroenterology & Hepatology·Azucena SalasNiels Vande Casteele
Jul 19, 2019·Drugs·Christopher MaVipul Jairath
Aug 28, 2020·Indian Journal of Gastroenterology : Official Journal of the Indian Society of Gastroenterology·Bhavik Bharat Shah, Mahesh Kumar Goenka
Feb 9, 2019·Digestive Diseases and Sciences·Roni WeisshofDavid T Rubin
Jun 18, 2019·Therapeutic Advances in Gastroenterology·Ferdinando D'AmicoSilvio Danese
Nov 7, 2019·Current Treatment Options in Gastroenterology·Anthony J ChoiDana J Lukin
Apr 2, 2020·Inflammatory Bowel Diseases·Freddy CalderaFrancis A Farraye
Oct 28, 2019·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·Longui NingGuoqiang Xu
May 23, 2020·Clinical and Experimental Gastroenterology·Edoardo TronconeGiovanni Monteleone
Jul 14, 2020·Therapeutic Advances in Musculoskeletal Disease·Flavia SunziniStefan Siebert
Aug 3, 2020·Gastroenterology Nursing : the Official Journal of the Society of Gastroenterology Nurses and Associates·Cynthia MorvilloSteven Stein
Apr 30, 2020·Alimentary Pharmacology & Therapeutics·Aysha H Al-AniBritt Christensen
Nov 10, 2020·MMW Fortschritte der Medizin·Eva BaerRaja Atreya
Dec 4, 2020·Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics
Dec 10, 2020·Inflammatory Bowel Diseases·Elleni J Pippis, Bruce R Yacyshyn
Aug 25, 2020·Gastroenterología y hepatología·Antonio López-SanrománEugeni Domènech
Oct 26, 2020·Gastroenterology·Edward L BarnesMichael D Kappelman
Jan 28, 2021·Annual Review of Medicine·Robert P Hirten, Bruce E Sands
Jan 30, 2021·Clinical Pharmacology in Drug Development·Camille VongArnab Mukherjee
Jan 12, 2021·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·Fabrizio BossaAngelo Andriulli
Oct 12, 2020·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Jean-Frederic ColombelWalter Reinisch

❮ Previous
Next ❯

Clinical Trials Mentioned

NCT00787202
NCT01465763
NCT01458951
NCT01458574
NCT01470612
NCT02538341

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of the American Academy of Dermatology
Kevin L WinthropHernan Valdez
The New England Journal of Medicine
William J SandbornOCTAVE Induction 1, OCTAVE Induction 2, and OCTAVE Sustain Investigators
© 2022 Meta ULC. All rights reserved